Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cacciatore

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Molecular Diagnosis & Therapy|June 27, 2018
The Presence of HLA-A Bw4-80I KIR Ligands Could Predict "Difficult-to-Treat" Psoriasis and Poor Response to EtanerceptM Guarene, A Pasi, V Bolcato, et al.
Lancet (London, England)|August 18, 1990
Outbreaks of drug-resistant tuberculosis at AIDS centreA E Pitchenik, J Burr, M Laufer, et al.
International Journal of STD & AIDS|April 6, 2006
Population-based enrolment of adolescents in a long-term follow-up trial of human papillomavirus vaccine efficacyM Lehtinen, I Idänpään-Heikkilä, T Lunnas, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Molecular Diagnosis & Therapy|June 27, 2018
The Presence of HLA-A Bw4-80I KIR Ligands Could Predict "Difficult-to-Treat" Psoriasis and Poor Response to EtanerceptM Guarene, A Pasi, V Bolcato, et al.
Lancet (London, England)|August 18, 1990
Outbreaks of drug-resistant tuberculosis at AIDS centreA E Pitchenik, J Burr, M Laufer, et al.
International Journal of STD & AIDS|April 6, 2006
Population-based enrolment of adolescents in a long-term follow-up trial of human papillomavirus vaccine efficacyM Lehtinen, I Idänpään-Heikkilä, T Lunnas, et al.
Pageof 2